基本情報
- 標準SMILES
O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Ce+4].[NH4+].[NH4+]- InChIKey
XMPZTFVPEKAKFH-UHFFFAOYSA-P- 分子式
- CeH8N8O18
- 平均分子量
- 548.22 g/mol
- 単同位体質量
- 547.9011
名称と識別子
- 優先名称
- Ceric ammonium nitrate
- IUPAC
- diazanium;cerium(4+);hexanitrate
- 英語名
- Cerium(IV) ammonium nitrate
- 分子式
- CeH4N2O3
- 分子量
- 220.16
名称と別名
名称をさらに表示
データベース識別子
- CAS
10139-51-2、16774-21-3- PubChem CID
- 180504
- UNII
- U99S55ED6B
- EC Number
- 240-827-6
物性
構造計算による物性
- 極性表面積
- 379 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 18
- 回転可能結合数
- 0
- 重原子数
- 27
- 形式電荷
- 0
- 複雑度
- 18
実験および物理化学的性質
安全と法規制
GHS分類
GHS Classification
Danger
H272 (99.4%): May intensify fire; oxidizer [Danger Oxidizing liquids; Oxidizing solids];H302 (92.6%): Harmful if swallowed [Warning Acute toxicity, oral];H314 (67.4%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H315 (28%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (66.3%): May cause an allergic skin reaction [Warning Sensitization, Skin];H318 (68%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (29.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (26.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H400 (65.1%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard];H410 (65.7%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard]
P210, P220, P260, P261, P264, P264+P265, P270, P271, P272, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P363, P370+P378, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 175 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
危険有害性情報
安全と保護具
Protective Action Criteria (PAC)
0.054 [mg/m3]
0.58 [mg/m3]
3.5 [mg/m3]
毒性情報
Treatment
Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution administered intravenously slowly over five minutes followed by IV flush with normal saline. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. (L1613)
Toxicity Summary
Nitrate's toxicity is a result of it's conversion to nitrite once in the body. Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. This elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)
Signs and Symptoms
Nitrate and nitrite poisoning causes methemoglobinemia. Symptoms include cyanosis, cardiac dysrhythmias and circulatory failure, and progressive central nervous system (CNS) effects. CNS effects can range from mild dizziness and lethargy to coma and convulsions. (L1137)
法規制情報
化学と産業
薬理情報
Metabolism/Metabolites
Intake of some amount of nitrates and nitrites is a normal part of the nitrogen cycle in humans. In vivo conversion of nitrates to nitrites can occur in the gastrointestional tract under the right conditions, significantly enhancing nitrates' toxic potency. The major metabolic pathway for nitrate is conversion to nitrite, and then to ammonia. Nitrites, nitrates, and their metabolites are excreted in the urine. (L1137)
用途と製造
関連反応
関連ノート
読み込み中…